Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
A director at Oracle Corporation (NYSE:ORCL) has made a significant stock purchase, according to a Form 4 filing with the Securities and Exchange Commission.
Read moreTruist Securities reiterated its Hold rating on Accenture plc (NYSE:ACN) on October 02, 2026.
Read moreWells Fargo reiterated its Equal-Weight rating on Accenture plc (NYSE:ACN) on October 02, 2026.
Read moreNewstead Jennifer, of Apple Inc. (NASDAQ:AAPL), sold 2,399 shares of company stock on September 29, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
Read moreSusquehanna reiterated its Positive rating on Union Pacific Corporation (NYSE:UNP) on October 02, 2026.
Read moreWells Fargo analysts initiated coverage on BlackRock, Inc. (NYSE:BLK) with a rating of Overweight on October 02, 2026.
Read morePiper Sandler reiterated its Neutral rating on The Charles Schwab Corporation (NYSE:SCHW) on October 02, 2026.
Read moreWells Fargo analysts initiated coverage on The Charles Schwab Corporation (NYSE:SCHW) with a rating of Equal-Weight on October 02, 2026.
Read moreWells Fargo analysts initiated coverage on Blackstone Inc. (NYSE:BX) with a rating of Equal-Weight on October 02, 2026.
Read moreRBC Capital reiterated its Outperform rating on Intuit Inc. (NASDAQ:INTU) on October 02, 2026.
Read moreRothschild & Co analysts upgraded Abbott Laboratories (NYSE:ABT) from Neutral to Buy on October 02, 2026.
Read moreCitizens reiterated its Market Outperform rating on Oracle Corporation (NYSE:ORCL) on October 02, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Connect Biopharma Holdings Limited (NASDAQ:CNTB) on October 02, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) on October 02, 2026.
Read moreBTIG analysts downgraded Foghorn Therapeutics Inc. (NASDAQ:FHTX) from Buy to Neutral on October 02, 2026.
Read moreAscendiant Capital analysts initiated coverage on Aether Holdings, Inc. Common Stock (NASDAQ:ATHR) with a rating of Buy on October 05, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on CervoMed Inc.
Read moreSentonas Michael, of CrowdStrike Holdings, Inc. Class A Common Stock (NASDAQ:CRWD), sold 41,974 shares of company stock on September 30, 2026, according to a Form 4 filing with…
Read moreChardan Capital reiterated its Buy rating on Agenus Inc. (NASDAQ:AGEN) on October 05, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Vanda Pharmaceuticals Inc.
Read more
